Application of the functionalized congener approach to dendrimer-based signaling agents acting through A2A adenosine receptors

Purinergic Signalling

Volumn 5, Issue 1, 2009, Pages 39-50

  Kim, Yoonkyung ^a,e   Klutz, Athena M ^a   Hechler, Béatrice ^b,c,d   Gao, Zhan Guo ^a   Gachet, Christian ^b,c,d   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b INSERM   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e Korea Institute of Science and Technology   (South Korea)

Author keywords

A2A adenosine receptors; Antithrombotic; Dendrimers; Functionalized congeners; G protein coupled receptors; Nanotechnology

Indexed keywords

EID: 60449089850     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-008-9113-3     Document Type: Article

References (36)

1. Lee CC, MacKay JA, Fréchet JMJ, Szoka FC (2005) Designing dendrimers for biological applications. Nature Biotechnol 23:1517-1526
2. Svenson S, Tomalia DA (2005) Dendrimers in biomedical applications-reflections on the field. Adv Drug Delivery Rev 57:2106-2129
3. Boas U, Heegaard PMH (2004) Dendrimers in drug research. Chem Soc Rev 33:43-63
4. Stiriba S-E, Frey H, Haag R (2002) Dendritic polymers in biomedical applications: From potential to clinical use in diagnostics and therapy. Angew Chem Int Ed 41:1329-1334
5. Tomalia DA (2005) Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog Polym Sci 30:294-324
6. Grayson SM, Fréchet JMJ (2001) Convergent dendrons and dendrimers: From synthesis to applications. Chem Rev 101:3819-3867
7. Zeng F, Zimmerman SC (1997) Dendrimers in supramolecular chemistry: From molecular recognition to self-assembly. Chem Rev 97:1681-l712
8. Mammen M, Choi S-K, Whitesides GM (1998) Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 37:2754-2794
9. Pin JP, Neubig R, Bouvier M, Devi L, Filizola M, Javitch JA, Lohse MJ, Milligan G, Palczewski K, Parmentier M, Spedding M (2007) International union of basic and clinical pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol Rev 59:5-13
10. Jacobson KA, Daly JW (1991) Purine functionalized congeners as molecular probes for adenosine receptors. Nucleosides and Nucleotides 10:1029-1038
11. 1-adenosine receptors. J Med Chem 28:1341-1346
12. Landry Y, Niederhoffer N, Sick E, Gies JP (2006) Heptahelical and other G-protein-coupled receptors (GPCRs) signaling. Curr Med Chem 13:51-63
13. Ratnala VR, Kiihne SR, Buda F, Leurs R, de Groot HJ, DeGrip WJ (2007) Solid-state NMR evidence for a protonation switch in the binding pocket of the H1 receptor upon binding of the agonist histamine. J Am Chem Soc 129:867-872
14. Jacobson KA, Gao Z-G (2006) Adenosine receptors as therapeutic targets. Nature Rev Drug Discovery 5:247-264
15. Yan L, Burbiel JC, Maass A, Müller CE (2003) Adenosine receptor agonists: From basic medicinal chemistry to clinical development. Expert Opin Emerg Drugs 8:537-576
16. Fredholm BB, IJzerman AP, Jacobson KA, Klotz K-N, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552
17. Kim Y, Hechler B, Klutz AM, Gachet C, Jacobson KA (2008) Toward multivalent signaling across G protein-coupled receptors from poly(amidoamine) dendrimers. Bioconjugate Chem. 19:406-411
18. 2 adenosine receptors. Naunyn-Schmeideberg's Arch Pharamacol 347:521-526
19. 2a adenosine receptors. Mol Pharm 42:123-133
20. 2 adenosine receptors. J Mol Recogn 2:170-178
21. Esfand R, Tomalia DA (2001) Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discovery Today 6:427-436
22. Kim Y, Klutz AM, Jacobson KA (2008) Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: Synthesis, characterization, and evaluation of cytotoxicity. Bioconjugate Chem 19 (in press)
23. Perreira M, Jiang JK, Klutz AM, Gao Z-G, Shainberg A, Lu C, Thomas CJ, Jacobson KA (2005) "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem 48:4910-4918
24. 2A adenosine receptor and its agonists. Chem Biol 12:237-247
25. 1 receptor measured by a yeast growth assay with comparisons to assays of phospholipase C and calcium mobilization in 1321N1 human astrocytoma cells. Purinergic Signalling 1:241-247
26. Cazenave JP, Ohlmann P, Cassel D, Eckly A, Hechler B, Gachet C (2004) Preparation of washed platelet suspensions from human and rodent blood. Methods Mol Biol 272:13-28
27. Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D'Emanuele A (2003) The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm 252:263-266
28. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T (2003) In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials 24:1121-1131
29. 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 65:133-148
30. Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H (2007) Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjugate Chem 18:2054-2060
31. Majoros IJ, Keszler B, Woehler S, Bull T, Baker JR Jr (2003) Acetylation of poly(amidoamine) dendrimers. Macromolecules 36:5526-5529
32. Majoros IJ, Thomas TP, Mehta CB, Baker JR Jr (2005) Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem 48:5892-5899
33. Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mulé J, Baker JR Jr (2002) Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 19:1310-1316
34. Lee H, Baker JR Jr, Larson RG (2006) Molecular dynamics studies of the size, shape, and internal structure of 0% and 90% acetylated fifth-generation polyamidoamine dendrimers in water and methanol. J Phys Chem B 110:4014-4019
35. Gachet C (2006) Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46:277-300
36. 2A receptor system using positron emission tomography. J Med Chem 43:4359-4362